MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 169 filers reported holding MEDICINES CO in Q4 2014. The put-call ratio across all filers is 1.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $247,173,000 | +7677.6% | 2,909,978 | +4479.0% | 0.18% | +5900.0% |
| Q3 2019 | $3,178,000 | +28.2% | 63,550 | -6.5% | 0.00% | +50.0% |
| Q2 2019 | $2,479,000 | +17.7% | 67,949 | -9.9% | 0.00% | 0.0% |
| Q1 2019 | $2,106,000 | +23.5% | 75,377 | -15.4% | 0.00% | 0.0% |
| Q4 2018 | $1,705,000 | +15.8% | 89,075 | +81.0% | 0.00% | +100.0% |
| Q3 2018 | $1,472,000 | -42.0% | 49,208 | -28.9% | 0.00% | -50.0% |
| Q2 2018 | $2,539,000 | -2.1% | 69,204 | -12.1% | 0.00% | 0.0% |
| Q1 2018 | $2,594,000 | +25.4% | 78,766 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $2,068,000 | -40.0% | 75,641 | -18.7% | 0.00% | -33.3% |
| Q3 2017 | $3,447,000 | +69.6% | 93,062 | +74.0% | 0.00% | +50.0% |
| Q2 2017 | $2,033,000 | -51.2% | 53,497 | -37.3% | 0.00% | -50.0% |
| Q1 2017 | $4,168,000 | +22.7% | 85,264 | -14.8% | 0.00% | +33.3% |
| Q4 2016 | $3,396,000 | +9.5% | 100,056 | +21.7% | 0.00% | 0.0% |
| Q3 2016 | $3,102,000 | -24.2% | 82,203 | -32.4% | 0.00% | -40.0% |
| Q2 2016 | $4,091,000 | +192.0% | 121,655 | +176.1% | 0.01% | +150.0% |
| Q1 2016 | $1,401,000 | -23.1% | 44,059 | -9.8% | 0.00% | 0.0% |
| Q4 2015 | $1,823,000 | -4.8% | 48,861 | -3.1% | 0.00% | 0.0% |
| Q3 2015 | $1,915,000 | -58.6% | 50,426 | -68.8% | 0.00% | -60.0% |
| Q2 2015 | $4,629,000 | +272.1% | 161,750 | +264.5% | 0.01% | +400.0% |
| Q1 2015 | $1,244,000 | -7.1% | 44,374 | -8.3% | 0.00% | 0.0% |
| Q4 2014 | $1,339,000 | -29.7% | 48,391 | -43.3% | 0.00% | -50.0% |
| Q3 2014 | $1,904,000 | -10.1% | 85,278 | +17.0% | 0.00% | 0.0% |
| Q2 2014 | $2,118,000 | -59.8% | 72,886 | -60.6% | 0.00% | -60.0% |
| Q1 2014 | $5,263,000 | +79.0% | 185,192 | +143.1% | 0.01% | +66.7% |
| Q4 2013 | $2,941,000 | +12.7% | 76,191 | -2.1% | 0.00% | 0.0% |
| Q3 2013 | $2,609,000 | +38.5% | 77,833 | +27.0% | 0.00% | +50.0% |
| Q2 2013 | $1,884,000 | +8.6% | 61,265 | +18.1% | 0.00% | 0.0% |
| Q1 2013 | $1,735,000 | – | 51,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |